Results 41 to 50 of about 5,850,068 (304)

The genetics of cardiovascular disease [PDF]

, 2008
Recent advances in genotyping technology and insights into disease mechanisms have increased interest in the genetics of cardiovascular disease. Several candidate genes involved in cardiovascular diseases were identified from studies using animal models,
Padmanabhan, S., Delles, C., Dominiczak, A.F., McBride, M.W.   +3 more
core   +1 more source

Prediction of Cardiovascular Events by Pulse Waveform Parameters: Analysis of CARTaGENE

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Waveform parameters provide approximate data about aortic wave reflection. However, their association with cardiovascular events remains controversial and their role in cardiovascular prediction is unknown.
Louis‐Charles Desbiens, Catherine Fortier, Annie‐Claire Nadeau‐Fredette, François Madore, Bernhard Hametner, Siegfried Wassertheurer, Mohsen Agharazii, Rémi Goupil   +7 more
doaj   +1 more source

Dysfunctional HDL and atherosclerotic cardiovascular disease [PDF]

Nature Reviews Cardiology, 2015
High-density lipoproteins (HDLs) protect against atherosclerosis by removing excess cholesterol from macrophages through the ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) pathways involved in reverse cholesterol transport.
Robert S, Rosenson, H Bryan, Brewer, Benjamin J, Ansell, Philip, Barter, M John, Chapman, Jay W, Heinecke, Anatol, Kontush, Alan R, Tall, Nancy R, Webb   +8 more
openaire   +2 more sources

Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease

, 2022
MicroRNAs (miRs) are promising diagnostic, prognostic and therapeutic biomolecules for atherosclerotic cardiovascular disease. Atherosclerotic occlusive disease concerns a large population of patients, carrying the highest incidence of fatal and non ...
Tadeusz Przewłocki, Badacz, Rafał, Kabłak-Ziembicka, Anna, Rafał Badacz, Anna Kabłak-Ziembicka, Przewłocki, Tadeusz   +5 more
core   +1 more source

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background FGF21 (fibroblast growth factor 21), a novel hepatokine regulating lipid metabolism, has been linked to atherosclerotic disease. However, whether this relationship exists in patients without nonalcoholic fatty liver disease is unclear.
Liang Wu, Lingling Qian, Lei Zhang, Jing Zhang, Jia Zhou, Yuehua Li, Xuhong Hou, Qichen Fang, Huating Li, Weiping Jia   +9 more
doaj   +1 more source

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview

Frontiers in Cardiovascular Medicine, 2021
With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually.
Min Wu, Zongliang Yu, Xiaoya Li, Xiaoya Li, Xiaonan Zhang, Songzi Wang, Shengjie Yang, Lanqing Hu, Longtao Liu   +8 more
doaj   +1 more source

Stress and Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis, 2014
Recent major advances in medical science have introduced a wide variety of treatments against atherosclerosis-based cardiovascular diseases, which has led to a significant reduction in mortality associated with these diseases. However, atherosclerosis-based cardiovascular disease remains a leading cause of death.
openaire   +3 more sources

Global Trends in Atherosclerotic Cardiovascular Disease

Clinical Therapeutics, 2023
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality, affecting over 523 million people globally. Atherosclerotic diseases, particularly ischemic heart disease (IHD) and stroke, are the primary mediators of CVD burden and trends, with half of CVD deaths attributed to IHD, and another quarter to ischemic stroke.
Lee Nedkoff, Tom Briffa, Dawit Zemedikun, Saranne Herrington, F. Lucy Wright   +4 more
openaire   +2 more sources

Chlamydia pneumoniae in atherosclerotic middle cerebral artery [PDF]

, 2001
Background and Purpose—Atherosclerotic middle cerebral arteries are frequent sites of thrombosis, leading to stroke. Previous studies have suggested a role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis.
Virók, Dezső, Intzédy, László, Burián, Katalin, Iványi, Béla, Gönczöl, Éva, Karai, László, Kis, Zoltán, Szabó, Árpád   +7 more
core   +1 more source

Ultra-short echo time cardiovascular magnetic resonance of atherosclerotic carotid plaque [PDF]

, 2010
Background Multi-contrast weighted cardiovascular magnetic resonance (CMR) allows detailed plaque characterisation and assessment of plaque vulnerability.
Sonia Nielles-Vallespin, Nielles-Vallespin, S, Firmin, DN, Chan, Cheuk F, Keenan, Niall G, Mary N Sheppard, Gatehouse, Peter, Chan Cheuk F, Firmin David N, Gatehouse, P, Keenan, NG, Sheppard, MN, Boyle, JJ, Peter Gatehouse, Chan, CF, Sheppard Mary N, Boyle Joseph J, Joseph J Boyle, Niall G Keenan, Nielles-Vallespin, Sonia, Boyle, Joseph J, Sheppard, Mary N, Pennell, Dudley J, Pennell, DJ, Pennell Dudley J, Gatehouse Peter, Dudley J Pennell, Nielles-Vallespin Sonia, David N Firmin, Cheuk F Chan, Keenan Niall G, Firmin, David N   +31 more
core   +1 more source